Catalog No.
FHH37212
Species reactivity
Human
Host species
Human
Isotype
IgG1, kappa
Clonality
Monoclonal
Conjugation
PE
Target
Membrane antigen MN, P54/58N, Carbonic anhydrase 9, Renal cell carcinoma-associated antigen G250, CA-IX, CAIX, pMW1, Carbonic anhydrase IX, RCC-associated antigen G250, Carbonate dehydratase IX, CA9, MN, G250
Concentration
0.5 mg/ml
Endotoxin level
Please contact with the lab for this information.
Accession
Q16790
Applications
FCM
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.
Stability and Storage
Store at 4°C for 12 months. Protect from light. Do not freeze.
Clone ID
SAA0152
Note
For research use only.
The role of molecular imaging in the characterization of renal masses., PMID:29319547
Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis., PMID:29342352
Nano-functionalized long-period fiber grating probe for disease-specific protein detection., PMID:32254518
Extracellular galectin-1 enhances adhesion to and invasion of oral epithelial cells by Porphyromonas gingivalis., PMID:29544077
Detection of high PD-L1 expression in oral cancers by a novel monoclonal antibody L1Mab-4., PMID:29556567
Enhanced Therapeutic Activity of Non-Internalizing Small-Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination with Targeted Interleukin-2., PMID:29691298
Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers., PMID:29715036
Positron Emission Tomography/Computed Tomography with 89Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion., PMID:29730017
Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ., PMID:29749469
Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab., PMID:29802988
CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target., PMID:29865880
Detection of high CD44 expression in oral cancers using the novel monoclonal antibody, C44Mab-5., PMID:29872736
Surface-Enhanced Raman Scattering Nanoparticles for Multiplexed Imaging of Bladder Cancer Tissue Permeability and Molecular Phenotype., PMID:30203645
Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma., PMID:30322727
Different expression patterns of carbonic anhydrase IX in oral lichen planus and leukoplakia., PMID:30383070
Radiolabeling of the antibody IgG M75 for epitope of human carbonic anhydrase IX by 61Cu and 64Cu and its biological testing., PMID:30391716
Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma., PMID:30635792
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial., PMID:30694523
CAIX Regulates Invadopodia Formation through Both a pH-Dependent Mechanism and Interplay with Actin Regulatory Proteins., PMID:31167468
New Monoclonal Antibodies for a Selective Detection of Membrane-Associated and Soluble Forms of Carbonic Anhydrase IX in Human Cell Lines and Biological Samples., PMID:31349673
Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts., PMID:31624303
Dynamic surveillance of tamoxifen-resistance in ER-positive breast cancer by CAIX-targeted ultrasound imaging., PMID:32048471
A bioconjugated MoS2 based nanoplatform with increased binding efficiency to cancer cells., PMID:32065173
New Gene Variants Associated with the Risk of Chronic HBV Infection., PMID:32297155
Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: From nanoscale analysis to clinical application., PMID:32392161
Identification of Novel Carbonic Anhydrase IX Inhibitors Using High-Throughput Screening of Pooled Compound Libraries by DNA-Linked Inhibitor Antibody Assay (DIANA)., PMID:32452709
Impact of Ligand Size and Conjugation Chemistry on the Performance of Universal Chimeric Antigen Receptor T-Cells for Tumor Killing., PMID:32515934
Effective inhibition of tumor in vivo with a novel DNA vaccine targeting chimeric G250., PMID:32706085
Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma., PMID:32816890
Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management., PMID:32998233
ZCCHC14 regulates proliferation and invasion of non-small cell lung cancer through the MAPK-P38 signalling pathway., PMID:33345444
Dual roles of AMAP1 in the transcriptional regulation and intracellular trafficking of carbonic anhydrase IX., PMID:34742153
First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors., PMID:35057692
GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors., PMID:35328229
Factors, associated with elevated concentration of soluble carbonic anhydrase IX in plasma of women with cervical dysplasia., PMID:36100684
Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities., PMID:36745503
18F-Fluoromisonidazole-Positron Emission Tomography and Immunohistochemistry Verified Tumor Oxygenation, Stemness, and Immunosupportive Microenvironment After Preoperative Neoadjuvant Bevacizumab for Newly Diagnosed Glioblastoma., PMID:37187346
Downregulation of HHLA2 inhibits ovarian cancer progression via the NF-κB signaling pathway and suppresses the expression of CA9., PMID:37210768
Immunohistochemical Characterization of a Large Cohort of Triple Negative Breast Cancer., PMID:37306115
Para-toluenesulfonamide, a novel potent carbonic anhydrase inhibitor, improves hypoxia-induced metastatic breast cancer cell viability and prevents resistance to αPD-1 therapy in triple-negative breast cancer., PMID:37748406
Aerobic vaginitis is associated with carbonic anhydrase IX in cervical intraepithelial neoplasia., PMID:38627429
[Modern view on the problem of diagnostics of renal angiomioadenomatous tumor]., PMID:38650412
Carbonic anhydrase IX: An atypical target for innovative therapies in cancer., PMID:38801961
Plasmodium vivax spleen-dependent protein 1 and its role in extracellular vesicles-mediated intrasplenic infections., PMID:38828264
Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma., PMID:38834201
Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma., PMID:38948062
Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial., PMID:39513196
Acid-exposed and hypoxic cancer cells do not overlap but are interdependent for unsaturated fatty acid resources., PMID:39572570
β1 Integrin/FAK signaling regulates interleukin-8 production in human gingival epithelial Ca9-22 cells., PMID:39826873
Antibody-drug conjugates and radioconjugates targeting carbonic anhydrase IX and XII in hypoxic tumors: Bench to clinical applications., PMID:40154235
For research use only. Not for human or drug use.
